Evidence map›Paper›PMID 35645180›Full record

ArticleBiomimetics (Basel, Switzerland)2022

Effect of Composition Strategies on Mycelium-Based Composites Flexural Behaviour.

Adrien Rigobello, Claudia Colmo, Phil Ayres

Abstract read
In one paragraph

Article in Biomimetics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Computational design logics for bio-based design.Architectural intelligence · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adrien RigobelloCentre for IT and Architecture, Royal Danish Academy, 1435 Copenhagen, Denmark.ORCID 0000-0003-0242-1514
Claudia ColmoCentre for IT and Architecture, Royal Danish Academy, 1435 Copenhagen, Denmark.
Phil AyresCentre for IT and Architecture, Royal Danish Academy, 1435 Copenhagen, Denmark.ORCID 0000-0002-9266-065X

Funding

European Union 858132
6 · The paper itself

Abstract

Mycelium-based composites (MBC) are a promising class of relatively novel materials that leverage mycelium colonisation of substrates. Being predicated on biological growth, rather than extraction based material sourcing from the geosphere, MBC are garnering attention as potential alternatives for certain fossil-based materials. In addition, their protocols of production point towards more sustainable and circular practices. MBC remains an emerging practice in both production and analysis of materials, particularly with regard to standardisation and repeatability of protocols. Here, we show a series of flexural tests following ASTM D1037, reporting flexural modulus and flexural modulus of rupture. To increase the mechanical proprieties, we contribute with an approach that follows the composition strategy of reinforcement by considering fibre topology and implementing structural components to the substrate. We explore four models that consist of a control group, the integration of inner hessian, hessian jacketing and rattan fibres. Apart from the inner hessian group, the introduction of rattan fibres and hessian jacketing led to significant increases in both strength and stiffness (α = 0.05). The mean of the flexural modulus for the most performative rattan series (1.34 GPa) is still close to three times lower than that of Medium-Density Fibreboard, and approximately 16 times lower in modulus of rupture. A future investigation could focus on developing a hybrid strategy of composition and densification so as to improve aggregate interlocking and resulting strength and stiffness.

Indexed as

biomaterialsmycelium-based compositenatural composites

Identifiers

PMID35645180
PMCPMC9149937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.